Merck, J&J and others won't be dropping their research to recreate the success seen in the early treatment of an HIV-positive child. More
-
-
Sponsored By:
-
Sponsored By:
MRK
Newborn Cured of HIV
A little girl in Mississippi, who was born infected with HIV, was apparently cured of the disease after receiving a three drug cocktail shortly after birth. More
Should I Buy Merck? 3 Pros, 3 Cons
Merck is in the midst of a prolonged downtrend after hitting multiyear highs in 2012. Should you get in, or keep avoiding the Big Pharma stock? More
Bausch & Lomb Prepping to Go Public?
A report says private equity investor Warburg Pincus is interviewing investment banks about a potential Bausch & Lomb IPO. More
2 Newer Names for Retirement Income
If you’re a retiree who needs income for living expenses, consider these new closed-end funds yielding more than 7%. More
Merck Settles Cholesterol Drug Lawsuits for $688M
Merck will pay $688 million to settle two shareholder lawsuits over a delay in the disclosure of trial results for its cholesterol druf Vytorin. More
Top 10 Dow Dividend Stocks for February
Income investors could do a lot worse than buying into these venerable blue chips -- especially the stock that continues to hold the crown. More
